These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1684845)

  • 41. Detection of a HindIII restriction fragment length polymorphism in the human phenol sulfotransferase (STP) locus.
    Henkel RD; Galindo LV; Dooley TP
    Hum Genet; 1995 Feb; 95(2):245-6. PubMed ID: 7860079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular genetics and human prostatic carcinoma.
    Collins VP; Kunimi K; Bergerheim U; Ekman P
    Acta Oncol; 1991; 30(2):181-5. PubMed ID: 1674204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
    Goyette MC; Cho K; Fasching CL; Levy DB; Kinzler KW; Paraskeva C; Vogelstein B; Stanbridge EJ
    Mol Cell Biol; 1992 Mar; 12(3):1387-95. PubMed ID: 1347643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic abnormalities of colorectal carcinoma.
    Wasylyshyn ML; Westbrook CA
    Hepatogastroenterology; 1992 Jun; 39(3):226-31. PubMed ID: 1505894
    [No Abstract]   [Full Text] [Related]  

  • 45. An additional HindIII polymorphism at the coagulation factor XIIIA locus.
    Iodice C; Novelletto A; Malaspina P; Persichetti F
    Nucleic Acids Res; 1990 Feb; 18(3):693. PubMed ID: 1968632
    [No Abstract]   [Full Text] [Related]  

  • 46. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new HindIII restriction fragment length polymorphism in the hemophilia A locus.
    Ahrens P; Kruse TA; Schwartz M; Rasmussen PB; Din N
    Hum Genet; 1987 Jun; 76(2):127-8. PubMed ID: 2886419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.
    Cho KR; Vogelstein B
    J Cell Biochem Suppl; 1992; 16G():137-41. PubMed ID: 1469893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A HindIII RFLP for the HPRT pseudogene on chromosome 3 (HPRTP1).
    Dobrovic A; Gareau P; Seifert AM; Messing K; Bradley WE
    Nucleic Acids Res; 1987 Feb; 15(3):1346. PubMed ID: 2881273
    [No Abstract]   [Full Text] [Related]  

  • 50. A variation in the HINDIII restriction pattern of the dystrophin gene DMD with cDMD probe 11-14.
    Handa V; Kaul A; Kumari D; Goyle S
    Hum Mutat; 2000; 15(2):204-5. PubMed ID: 10649500
    [No Abstract]   [Full Text] [Related]  

  • 51. D6S110 detects polymorphic HindIII fragments associated with individual HLA-A class I haplotypes.
    Chorney MJ; Le Gall JY; Drysdale JW
    Nucleic Acids Res; 1991 Jan; 19(1):200. PubMed ID: 1672749
    [No Abstract]   [Full Text] [Related]  

  • 52. A HindIII polymorphism in the 3' end of the human alpha 1(IV) collagen gene.
    Tikka L; Roiko K; Soininen R; Prockop DJ; Tryggvason K
    Nucleic Acids Res; 1987 Jul; 15(13):5497. PubMed ID: 2885807
    [No Abstract]   [Full Text] [Related]  

  • 53. A HindIII polymorphism identified by a DNA clone which maps to chromosome 17 (D17S245).
    Brook JD; Upadhyaya M; Broadhead W; Rundle SA; Walsh KV; Harley HG; Shaw DJ
    Nucleic Acids Res; 1990 Feb; 18(4):1085. PubMed ID: 1969143
    [No Abstract]   [Full Text] [Related]  

  • 54. Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.
    Srivatsan ES; Misra BC; Venugopalan M; Wilczynski SP
    Am J Hum Genet; 1991 Oct; 49(4):868-77. PubMed ID: 1680288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HindIII(+/-) polymorphism of the Y chromosome, blood pressure, and serum lipids: no evidence of association in three white populations.
    Russo P; Venezia A; Lauria F; Strazzullo P; Cappuccio FP; Iacoviello L; Barba G; Siani A
    Am J Hypertens; 2006 Apr; 19(4):331-8. PubMed ID: 16580565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.
    Yokota T; Matsumoto S; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Jpn J Cancer Res; 1997 Oct; 88(10):959-64. PubMed ID: 9414657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Restriction fragment length polymorphisms detected by anonymous DNA probes mapped to defined intervals of human chromosome 16.
    Hyland VJ; Grist S; Sutherland GR
    Hum Genet; 1988 Jul; 79(3):277-9. PubMed ID: 2900214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A moderately frequent HindIII polymorphism at the human NGFR locus (17q12----17q22).
    Wright EC; Fain PR; Barker DF; Chao MV
    Nucleic Acids Res; 1989 Jan; 17(2):825. PubMed ID: 2563584
    [No Abstract]   [Full Text] [Related]  

  • 59. The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
    Meling GI; Lothe RA; Børresen AL; Graue C; Hauge S; Clausen OP; Rognum TO
    Br J Cancer; 1993 Jan; 67(1):88-92. PubMed ID: 8094008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
    Brewster SF; Gingell JC; Browne S; Brown KW
    Br J Cancer; 1994 Oct; 70(4):697-700. PubMed ID: 7917921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.